Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$499M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
Amazon
AMZN
|
+$286M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$224M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$248M |
| 2 |
LPT
Liberty Property Trust
LPT
|
+$148M |
| 3 |
Procter & Gamble
PG
|
+$122M |
| 4 |
Visa
V
|
+$92.4M |
| 5 |
MDCO
Medicines Co
MDCO
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.12% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.68% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Medallion Financial
MFIN
$249M
| $493K | ﹤0.01% |
265,324
+20,647
| +8% | +$115K |
|
|
TTOO
3252
DELISTED
T2 Biosystems, Inc
TTOO
| $493K | ﹤0.01% |
152
+76
| +100% | +$316K |
|
|
CIICU
3253
DELISTED
CIIG Merger Corp. Units
CIICU
| $489K | ﹤0.01% |
50,000
-100,000
| -67% | -$1.02M |
|
|
MNTX
3254
DELISTED
Manitex International, Inc.
MNTX
| $489K | ﹤0.01% |
118,603
+1,069
| +0.9% | +$5.61K |
|
|
DZSI
3255
DELISTED
DZS Inc. Common Stock
DZSI
| $487K | ﹤0.01% |
116,300
+4,136
| +4% | +$31.6K |
|
|
SI
3256
DELISTED
Silvergate Capital Corporation
SI
| $485K | ﹤0.01% |
50,856
+16,017
| +46% | +$227K |
|
|
SYBX
3257
DELISTED
Synlogic
SYBX
| $484K | ﹤0.01% |
18,762
+2,058
| +12% | +$72.9K |
|
|
RLH
3258
DELISTED
Red Lions Hotel Corporation
RLH
| $484K | ﹤0.01% |
332,188
+9,099
| +3% | +$24.3K |
|
|
KG
3259
Kestrel Group
KG
$68.9M
| $483K | ﹤0.01% |
26,544
-972
| -4% | -$16.5K |
|
3260
Takeda Pharmaceutical
TAK
$53.4B
| $483K | ﹤0.01% |
31,865
-31,109
| -49% | -$564K |
|
|
MBII
3261
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $482K | ﹤0.01% |
590,965
+53,374
| +10% | +$56.6K |
|
|
TCS
3262
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $477K | ﹤0.01% |
13,483
+420
| +3% | +$23.3K |
|
|
TESS
3263
DELISTED
Tessco Technologies Inc
TESS
| $477K | ﹤0.01% |
97,580
+1,876
| +2% | +$13.9K |
|
3264
NextDecade
NEXT
$1.71B
| $476K | ﹤0.01% |
253,703
+18,273
| +8% | +$73.4K |
|
3265
Forte Biosciences
FBRX
$1.57B
| $475K | ﹤0.01% |
1,039
+161
| +18% | +$62.9K |
|
|
RESN
3266
DELISTED
Resonant Inc.
RESN
| $475K | ﹤0.01% |
321,384
+127,896
| +66% | +$246K |
|
|
DFPHU
3267
DELISTED
DFP Healthcare Acquisitions Corp. Unit
DFPHU
| $475K | ﹤0.01% |
+50,000
| New | +$491K |
|
3268
Cibus
CBUS
$147M
| $468K | ﹤0.01% |
2,815
+93
| +3% | +$25.8K |
|
|
GRTX
3269
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $467K | ﹤0.01% |
49,217
+11,843
| +32% | +$153K |
|
3270
LG Display
LPL
$3.26B
| $463K | ﹤0.01% |
104,384
+31,542
| +43% | +$188K |
|
3271
Afya
AFYA
$1.25B
| $462K | ﹤0.01% |
+24,291
| New | +$602K |
|
|
SREV
3272
DELISTED
ServiceSource International, Inc.
SREV
| $462K | ﹤0.01% |
527,751
+3,872
| +0.7% | +$5.75K |
|
|
ABB
3273
DELISTED
ABB Ltd
ABB
| $461K | ﹤0.01% |
26,734
+4,032
| +18% | +$88.1K |
|
3274
United Bancorp
UBCP
$94.9M
| $459K | ﹤0.01% |
41,665
| – | – |
|
|
FLNA
3275
Filana Therapeutics
FLNA
$46.4M
| $458K | ﹤0.01% |
111,497
-32,754
| -23% | -$217K |
|
Similar funds
Geode Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Geode Capital Management held 4,292 positions worth $384B, down 20% from $478B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geode Capital Management's Q1 2020 filing shows 103 new, 3,113 increased, 564 reduced and 177 closed positions. Its largest new stake was Perdoceo Education: 1,042,040 shares worth $11.2M. The largest sale was Wellcare Health Plans, Inc., an estimated $248M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q1 2020 buy was Perdoceo Education: 1,042,040 shares worth $11.2M.
- Geode Capital Management added most to Apple in Q1 2020, an estimated $499M increase.
- Geode Capital Management's biggest Q1 2020 reduction was Procter & Gamble, cutting an estimated $122M.
- Geode Capital Management fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $248M.
- Geode Capital Management's ten largest holdings make up 21% of its $384B portfolio in Q1 2020.
- Geode Capital Management opened 103 new positions and closed 177 in Q1 2020.
- Geode Capital Management's portfolio value fell 20% quarter-over-quarter to $384B.
Based on Geode Capital Management's 13F filing for Q1 2020, filed 14 May 2020.